Sato-Nagaoka, Y., Suzuki, S., Suzuki, S., & Takahashi, S. Combination of triciribine and p38 MAPK inhibitor PD169316 enhances the differentiation effect on myeloid leukemia cells. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationSato-Nagaoka, Yuri, Susumu Suzuki, Souma Suzuki, and Shinichiro Takahashi. Combination of Triciribine and P38 MAPK Inhibitor PD169316 Enhances the Differentiation Effect on Myeloid Leukemia Cells. Public Library of Science (PLoS).
MLA (9th ed.) CitationSato-Nagaoka, Yuri, et al. Combination of Triciribine and P38 MAPK Inhibitor PD169316 Enhances the Differentiation Effect on Myeloid Leukemia Cells. Public Library of Science (PLoS).
Warning: These citations may not always be 100% accurate.